- Home
- GITS vs ADIL Comparison
GITS vs ADIL Comparison
Compare GITS & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GITS
- ADIL
- Stock Information
- Founded
- GITS 2018
- ADIL 2010
- Country
- GITS South Korea
- ADIL United States
- Employees
- GITS N/A
- ADIL N/A
- Industry
- GITS
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- GITS
- ADIL Health Care
- Exchange
- GITS Nasdaq
- ADIL Nasdaq
- Market Cap
- GITS 7.0M
- ADIL 7.7M
- IPO Year
- GITS N/A
- ADIL 2018
- Fundamental
- Price
- GITS $2.07
- ADIL $0.38
- Analyst Decision
- GITS
- ADIL Strong Buy
- Analyst Count
- GITS 0
- ADIL 2
- Target Price
- GITS N/A
- ADIL $4.75
- AVG Volume (30 Days)
- GITS 16.8K
- ADIL 737.3K
- Earning Date
- GITS 11-19-2025
- ADIL 11-12-2025
- Dividend Yield
- GITS N/A
- ADIL N/A
- EPS Growth
- GITS N/A
- ADIL N/A
- EPS
- GITS N/A
- ADIL N/A
- Revenue
- GITS $29.00
- ADIL N/A
- Revenue This Year
- GITS N/A
- ADIL N/A
- Revenue Next Year
- GITS N/A
- ADIL N/A
- P/E Ratio
- GITS N/A
- ADIL N/A
- Revenue Growth
- GITS N/A
- ADIL N/A
- 52 Week Low
- GITS $0.87
- ADIL $0.22
- 52 Week High
- GITS $9.78
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- GITS 38.31
- ADIL 59.20
- Support Level
- GITS $2.21
- ADIL $0.33
- Resistance Level
- GITS $2.47
- ADIL $0.41
- Average True Range (ATR)
- GITS 0.14
- ADIL 0.02
- MACD
- GITS -0.03
- ADIL 0.01
- Stochastic Oscillator
- GITS 2.97
- ADIL 74.89
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.